Pfizer uses two Cationic liposomes for their LNPs: ALC-0315 & ALC-0159.

"ALC-0315 is an ionizable lipid which has been used to form lipid nanoparticles for delivery of RNA. ALC-0315 is one of the components in the BNT162b2 vaccine against SARS-CoV-2 in addition to ALC-0159, DSPC, and cholesterol."

"This product is for research use only and not for human use."

Cationic liposomes are only used in clinical trials in terminally ill patients, due to high biochemical reactivity.

"The cationic liposomes showed a dose-dependent toxicity and were found to be most toxic for cells of macrophage origin."

Biodistribution LNPs, Japanese Pfizer FOIA:

Everyone focuses on ovaries, look at bone marrow, which is the birthplace of your red and white blood cells (home of your bone marrow macrophages).

Creativity impulse: What if cationic liposomes are distributed to the bone marrow ? Let your fantasy run wild. We are in uncharted territory here anyway.

Full Immunology101 VS Immunomythology Wailing Wall

@LoveNotVaccines